Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, December 6, 2024 
[ 03:01 AM ] - The Motley Fool
[ 02:01 AM ] - Business Standard
[ 01:01 AM ] - The Motley Fool
[ 12:01 AM ] - The Motley Fool
Thu, December 5, 2024 
[ 11:01 PM ] - MSN
[ 10:01 PM ] - marketindex
[ 09:31 PM ] - The Motley Fool UK
[ 07:31 PM ] - The Globe and Mail
Here's Why Astrazeneca (AZN) is a Strong Momentum Stock
- Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research service can help you become a smarter,
The article from MSN Money discusses why AstraZeneca (AZN) is considered a strong momentum stock. It highlights that AstraZeneca has shown significant positive momentum in its stock price, with a 1.86% increase last week and a 10.8% rise over the past month, outperforming the Zacks Large Cap Pharmaceuticals industry. Over the last year, the stock has surged by 23.5%, compared to the S&P 500's 27.7% increase. The article points out that momentum investors look for stocks with strong price trends, and AstraZeneca fits this profile with its recent performance metrics. Additionally, the company's earnings estimates have been revised upwards, with the current quarter's estimates increasing by 1.86% and the full year's by 1.52% over the last 30 days. This positive revision in earnings estimates, combined with its stock price momentum, supports the argument for AstraZeneca being a strong momentum stock.
Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/savingandinvesting/here-s-why-astrazeneca-azn-is-a-strong-momentum-stock/ar-AA1vkS0e ]
Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/savingandinvesting/here-s-why-astrazeneca-azn-is-a-strong-momentum-stock/ar-AA1vkS0e ]
Contributing Sources
